Cargando…
GSTM3 Function and Polymorphism in Cancer: Emerging but Promising
Cancer is a major cause of human mortality; however, the molecular mechanisms and proteomic biomarkers that cause tumor progression in malignant tumors are either unknown or only partially revealed. Glutathione S-transferases mu3 (GSTM3), which belongs to a family of xenobiotic detoxifying phase II...
Autores principales: | Wang, Shunda, Yang, Jinshou, You, Lei, Dai, Menghua, Zhao, Yupei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585806/ https://www.ncbi.nlm.nih.gov/pubmed/33116892 http://dx.doi.org/10.2147/CMAR.S272467 |
Ejemplares similares
-
Mucins in pancreatic cancer: A well‐established but promising family for diagnosis, prognosis and therapy
por: Wang, Shunda, et al.
Publicado: (2020) -
Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
por: Wang, Shunda, et al.
Publicado: (2020) -
Quantitative assessment of the diagnostic role of mucin family members in pancreatic cancer: a meta-analysis
por: Wang, Shunda, et al.
Publicado: (2021) -
Research Progress on Slit/Robo Pathway in Pancreatic Cancer: Emerging and Promising
por: Ding, Cheng, et al.
Publicado: (2020) -
High Expression of MUC15 Is Correlated with Poor Prognosis of Pancreatic Cancer and Promotes Migration, Invasion, and Chemo-Resistance In Vitro
por: Wang, Shunda, et al.
Publicado: (2020)